CN101726463B - 一种用酶比色反应测定β-羟丁酸的方法及其配用的试剂盒和其用途 - Google Patents
一种用酶比色反应测定β-羟丁酸的方法及其配用的试剂盒和其用途 Download PDFInfo
- Publication number
- CN101726463B CN101726463B CN2009101556381A CN200910155638A CN101726463B CN 101726463 B CN101726463 B CN 101726463B CN 2009101556381 A CN2009101556381 A CN 2009101556381A CN 200910155638 A CN200910155638 A CN 200910155638A CN 101726463 B CN101726463 B CN 101726463B
- Authority
- CN
- China
- Prior art keywords
- beta
- hydroxybutyric acid
- reagent
- hydroxybutyric
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 title claims abstract description 152
- 238000000034 method Methods 0.000 title claims abstract description 31
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 50
- 210000002966 serum Anatomy 0.000 claims abstract description 22
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 15
- 229950006238 nadide Drugs 0.000 claims abstract description 15
- 101710088194 Dehydrogenase Proteins 0.000 claims abstract description 13
- 238000002835 absorbance Methods 0.000 claims abstract description 13
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims abstract description 8
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 21
- 230000004044 response Effects 0.000 claims description 17
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 12
- LZGAZHLZLQYTKS-UHFFFAOYSA-N [N+](=O)([O-])C1=NN=NN1.[I] Chemical compound [N+](=O)([O-])C1=NN=NN1.[I] LZGAZHLZLQYTKS-UHFFFAOYSA-N 0.000 claims description 11
- 238000013016 damping Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 235000006408 oxalic acid Nutrition 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000006356 dehydrogenation reaction Methods 0.000 claims description 3
- 208000007976 Ketosis Diseases 0.000 abstract description 6
- 230000008859 change Effects 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 230000035484 reaction time Effects 0.000 abstract description 2
- 239000012472 biological sample Substances 0.000 abstract 2
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 abstract 1
- 208000005374 Poisoning Diseases 0.000 abstract 1
- PUXHGERAZSLLSU-UHFFFAOYSA-N [Cl-].[N+](=O)([O-])C1=NN=N[NH+]1I Chemical compound [Cl-].[N+](=O)([O-])C1=NN=N[NH+]1I PUXHGERAZSLLSU-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 abstract 1
- 238000000105 evaporative light scattering detection Methods 0.000 abstract 1
- 230000004140 ketosis Effects 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 231100000572 poisoning Toxicity 0.000 abstract 1
- 230000000607 poisoning effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 206010023379 Ketoacidosis Diseases 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000003556 assay Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101556381A CN101726463B (zh) | 2009-12-24 | 2009-12-24 | 一种用酶比色反应测定β-羟丁酸的方法及其配用的试剂盒和其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101556381A CN101726463B (zh) | 2009-12-24 | 2009-12-24 | 一种用酶比色反应测定β-羟丁酸的方法及其配用的试剂盒和其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101726463A CN101726463A (zh) | 2010-06-09 |
CN101726463B true CN101726463B (zh) | 2011-10-05 |
Family
ID=42447672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101556381A Active CN101726463B (zh) | 2009-12-24 | 2009-12-24 | 一种用酶比色反应测定β-羟丁酸的方法及其配用的试剂盒和其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101726463B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102435749B (zh) * | 2011-09-02 | 2013-10-16 | 宁波美康生物科技股份有限公司 | 用循环酶法测定β-羟丁酸的液体稳定试剂盒 |
CN104730230B (zh) * | 2013-12-23 | 2016-08-17 | 上海复星医药(集团)股份有限公司 | D-3-羟丁酸酶法检测试剂盒及其制备方法 |
CN104198407A (zh) * | 2014-08-14 | 2014-12-10 | 上海睿康生物科技有限公司 | 稳定酶法检测血清中β-羟丁酸含量的检测试剂盒 |
CN105510255A (zh) * | 2015-12-24 | 2016-04-20 | 江苏迈源生物科技有限公司 | 一种β-羟丁酸的测定方法及其测定试剂盒 |
CN111020003A (zh) * | 2019-12-27 | 2020-04-17 | 桂林英美特生物技术研究所 | 一种液体稳定的β-羟丁酸测定试剂 |
CN111735811A (zh) * | 2020-08-12 | 2020-10-02 | 民康医疗科技(天津)有限公司 | 一种甘油三酯的检测试剂、检测试纸及试纸制备方法 |
CN116297435A (zh) * | 2023-05-15 | 2023-06-23 | 北京索莱宝科技有限公司 | 乙酰乙酸含量检测试剂盒、其使用方法和检测装置 |
-
2009
- 2009-12-24 CN CN2009101556381A patent/CN101726463B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101726463A (zh) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101726463B (zh) | 一种用酶比色反应测定β-羟丁酸的方法及其配用的试剂盒和其用途 | |
US10591495B2 (en) | Device and methods of using device for detection of hyperammonemia | |
CN102435749A (zh) | 用循环酶法测定β-羟丁酸的液体稳定试剂盒 | |
Khadilkar et al. | Current concepts in blood glucose monitoring | |
Wu et al. | Chemiluminescence biosensor system for lactic acid using natural animal tissue as recognition element | |
Wiener | Whole blood glucose: what are we actually measuring? | |
Li et al. | A novel immobilization multienzyme glucose fluorescence capillary biosensor | |
Harborn et al. | Evaluation of a miniaturized thermal biosensor for the determination of glucose in whole blood | |
CN103048282B (zh) | 一种胆红素的检测方法及检测试剂盒 | |
CN104990913B (zh) | 一种基于金纳米颗粒生长检测葡萄糖的方法 | |
Liang et al. | 1, 5-anhydroglucitol biosensor based on light-addressable potentiometric sensor with RGO-CS-Fc/Au NPs nanohybrids | |
CN104730230A (zh) | D-3-羟丁酸酶法检测试剂盒及其制备方法 | |
Wahl | How accurately do we measure blood glucose levels in intensive care unit (ICU) patients? | |
CN111751523B (zh) | 一种基于微流控芯片和智能手机的生化指标检测装置 | |
CN103837685B (zh) | 一种血葡萄糖的检测方法及检测试剂盒 | |
Narla et al. | Critical care glucose point-of-care testing | |
CN111455020A (zh) | 一种1,5-脱水山梨醇检测试剂盒及检测方法 | |
CN108007922B (zh) | 一种采用酶化学发光法检测葡萄糖的试剂盒 | |
WO2020041591A1 (en) | Chemical detection assays | |
CN116482204A (zh) | 用于电化学酮检测和测量的系统和方法 | |
Singh et al. | Reusable glucose sensor based on enzyme immobilized egg-shell membrane | |
CN109837270B (zh) | 一种使肌醇脱氢酶、酮胺氧化酶和鞘磷脂酶在液体中长期稳定的方法 | |
CN105734113B (zh) | 一种酶法检测d-3-羟丁酸的试剂盒及其制备方法 | |
CN201828565U (zh) | 血糖含量测定试剂盒 | |
CN107664619A (zh) | 一种游离脂肪酸测定试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NINGBO REE BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG WEN Effective date: 20110915 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110915 Address after: Jiangbei District, Ningbo City Hing Yonglu 315021 No. 88 Ningbo Ruiyuan Biological Technology Co. Ltd. Applicant after: Ningbo Rui Bio-technology Co., Ltd. Address before: Jiangbei District in Zhejiang province 315021 Hing Ningbo Yonglu No. 88 Ningbo Ruiyuan Biological Technology Co. Ltd. Applicant before: Zhang Wen |